Letrozole After Tamoxifen in Treating Women With Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

5,187

Participants

Timeline

Start Date

August 24, 1998

Primary Completion Date

August 22, 2003

Study Completion Date

October 31, 2003

Conditions
Breast Cancer
Interventions
DRUG

letrozole

Given orally

OTHER

placebo

Given orally

Trial Locations (57)

T1J 1W5

Lethbridge Cancer Centre, Lethbridge

V1Y 5L3

BCCA - Cancer Centre for the Southern Interior, Kelowna

V9S 2B7

NRGH - Nanaimo Cancer Clinic, Nanaimo

V2A 3G6

Penticton Regional Hospital, Penticton

V3V 1Z2

BCCA - Fraser Valley Cancer Centre, Surrey

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

V8R 6V5

BCCA - Vancouver Island Cancer Centre, Victoria

R3E 0V9

CancerCare Manitoba, Winnipeg

E1C 6Z8

The Moncton Hospital, Moncton

E1C 8X3

The Vitalite Health Network - Dr. Leon Richard, Moncton

E2L 4L2

Atlantic Health Sciences Corporation, Saint John

AIB 3V6

Dr. H. Bliss Murphy Cancer Centre, St. John's

B3H 1V7

QEII Health Sciences Center, Halifax

L4M 6M2

The Royal Victoria Hospital, Barrie

P3E 5J1

Regional Cancer Program of the Hopital Regional, Greater Sudbury

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

K7L 5P9

Cancer Centre of Southeastern Ontario at Kingston, Kingston

N6A 4L6

London Regional Cancer Program, London

L6B 1A1

Markham Stouffville Hospital, Markham

L5M 2N1

Credit Valley Hospital, Mississauga

L3Y 2P9

Stronach Regional Health Centre at Southlake, Newmarket

L1G 2B9

Lakeridge Health Oshawa, Oshawa

K1H 8L6

Ottawa Health Research Institute - General Division, Ottawa

K9H 7B6

Peterborough Regional Health Centre, Peterborough

P6B 0A8

Algoma District Cancer Program, Sault Ste. Marie

L2R 7C6

Niagara Health System, St. Catharines

P7B 6V4

Thunder Bay Regional Health Science Centre, Thunder Bay

M2K 1E1

North York General Hospital, Toronto

M4C 3E7

Toronto East General Hospital, Toronto

M4N 3M5

Odette Cancer Centre, Toronto

M5B 1W8

St. Michael's Hospital, Toronto

M5G 1X5

Mount Sinai Hospital, Toronto

M5G 2C4

Univ. Health Network-The Toronto General Hospital, Toronto

M5G 2M9

Univ. Health Network-Princess Margaret Hospital, Toronto

M6R 1B5

St. Joseph's Health Centre, Toronto

M9C 1A5

Trillium Health Centre - West Toronto, Toronto

M9N 1N8

Humber River Regional Hospital, Toronto

N8W 2X3

Windsor Regional Cancer Centre, Windsor

C1A 8T5

PEI Cancer Treatment Centre,Queen Elizabeth Hospital, Charlottetown

J8P 7H2

Centre de Sante et de services sociaux de Gatineau, Gatineau

G6V 3Z1

L'Hotel-Dieu de Levis, Lévis

H1T 2M4

Hopital Maisonneuve-Rosemont, Montreal

H2L 4M1

CHUM - Hopital Notre-Dame, Montreal

H2W 1S6

McGill University - Dept. Oncology, Montreal

H2W 1T8

CHUM - Hotel Dieu du Montreal, Montreal

H3X 3J4

CHUM - Pavillon Saint-Luc, Montreal

H4J 1C5

Hopital du Sacre-Coeur de Montreal, Montreal

G1R 2J6

CHUQ-Pavillon Hotel-Dieu de Quebec, Québec

G1S 4L8

CHA-Hopital Du St-Sacrement, Québec

G1V 4G5

University Institute of Cardiology and, Québec

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

SW3 6JJ

The Royal Marsden NHS Foundation Trust, London

M23 9LT

Wythenshawe Hospital, Manchester

M2O 4BX

Christie's Hospital NHS Trust, Manchester

SM2 5PT

The Royal Marsden NHS Foundation Trust - Sutton, Surrey

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

North Central Cancer Treatment Group

NETWORK

collaborator

ETOP IBCSG Partners Foundation

NETWORK

collaborator

Eastern Cooperative Oncology Group

NETWORK

collaborator

SWOG Cancer Research Network

NETWORK

collaborator

Cancer and Leukemia Group B

NETWORK

collaborator

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

lead

NCIC Clinical Trials Group

NETWORK